Correlation Between Omkar Speciality and Biofil Chemicals

Can any of the company-specific risk be diversified away by investing in both Omkar Speciality and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Omkar Speciality and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Omkar Speciality Chemicals and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Omkar Speciality and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Omkar Speciality with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Omkar Speciality and Biofil Chemicals.

Diversification Opportunities for Omkar Speciality and Biofil Chemicals

-0.39

Correlation Coefficient

Omkar Speciality  Biofil Chemicals

Very good diversification

The 3 months correlation between Omkar and Biofil is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Omkar Speciality Chemicals and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Omkar Speciality is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Omkar Speciality Chemicals are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Omkar Speciality i.e., Omkar Speciality and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Omkar Speciality and Biofil Chemicals

Assuming the 90 days trading horizon Omkar Speciality Chemicals is expected to under-perform the Biofil Chemicals. But the stock apears to be less risky and, when comparing its historical volatility, Omkar Speciality Chemicals is 1.27 times less risky than Biofil Chemicals. The stock trades about -0.02 of its potential returns per unit of risk. The Biofil Chemicals Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  6,395  in Biofil Chemicals Pharmaceuticals on August 31, 2024 and sell it today you would lose (118.00) from holding Biofil Chemicals Pharmaceuticals or give up 1.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Omkar Speciality Chemicals  vs.  Biofil Chemicals Pharmaceutica

Omkar Speciality Che

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Omkar Speciality Chemicals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, Omkar Speciality is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Biofil Chemicals Pha

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Omkar Speciality and Biofil Chemicals

The main advantage of trading using opposite Omkar Speciality and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Omkar Speciality position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.

The idea behind Omkar Speciality Chemicals and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.